Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersDermatology Physician in Owensboro, KY
NPI: 1215042429Primary Practice Location
Henderson Dermatology
2821 New Hartford Rd, Owensboro, KY
Primary Employer
Henderson Dermatology
ourfamilyderm.com
HQ Phone
Get M.D. Artis's Phone Numberphone_androidMobile
Get M.D. Artis's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 1,208 | 1,886 |
| 2 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 860 | 1,553 |
| 3 | 17000Destruction of skin growth | 550 | 763 |
| 4 | 11102Tangential biopsy of single skin lesion | 442 | 540 |
| 5 | 17003Destruction of 2-14 skin growths | 405 | 2,703 |
A Case of Syringocystadenocarcinoma Papilliferum: Not Your Usual Suspect.
Authors: Bashinskaya, Alena, Shapiro, Lucas, Thompson, Conner, Truett, Artis P, Moody, Patricia
Journal: Cureus
Publication Date: 2023-05-24
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Secukinumab
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab
